Lawsuit Overview
September 12, 2016 (Shareholders Foundation) - An investor who currently holds shares of Medivation Inc (NASDAQ:MDVN), filed a lawsuit in effort to halt the proposed takeover of Medivation Inc by Pfizer Inc. for $81.50 per share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:MDVN stockholders by agreeing to sell Medivation Inc too cheaply vi...
You must register (for free) or login to view the entire case.